Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 6
1985 5
1986 1
1987 1
1989 1
1990 1
1991 4
1993 1
1994 3
1995 1
1996 1
1997 1
1998 1
1999 3
2000 3
2003 2
2005 1
2008 1
2009 1
2011 1
2012 4
2013 6
2014 2
2015 1
2016 3
2017 1
2018 1
2021 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for extended treatment of venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI; AMPLIFY-EXT Investigators. Agnelli G, et al. N Engl J Med. 2013 Feb 21;368(8):699-708. doi: 10.1056/NEJMoa1207541. Epub 2012 Dec 8. N Engl J Med. 2013. PMID: 23216615 Free article. Clinical Trial.
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism.
Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, Grosso MA, Kakkar AK, Kovacs MJ, Mercuri MF, Meyer G, Segers A, Shi M, Wang TF, Yeo E, Zhang G, Zwicker JI, Weitz JI, Büller HR; Hokusai VTE Cancer Investigators. Raskob GE, et al. N Engl J Med. 2018 Feb 15;378(7):615-624. doi: 10.1056/NEJMoa1711948. Epub 2017 Dec 12. N Engl J Med. 2018. PMID: 29231094 Free article. Clinical Trial.
Oral apixaban for the treatment of acute venous thromboembolism.
Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI; AMPLIFY Investigators. Agnelli G, et al. N Engl J Med. 2013 Aug 29;369(9):799-808. doi: 10.1056/NEJMoa1302507. Epub 2013 Jul 1. N Engl J Med. 2013. PMID: 23808982 Free article. Clinical Trial.
Management of antithrombin deficiency.
Pabinger-Fasching I. Pabinger-Fasching I. Clin Adv Hematol Oncol. 2023 May;21(5):232-234. Clin Adv Hematol Oncol. 2023. PMID: 37145492 No abstract available.
[Blood coagulation disorders in leukemia].
Pabinger-Fasching I. Pabinger-Fasching I. Wien Med Wochenschr. 1991;141(9-10):213-6. Wien Med Wochenschr. 1991. PMID: 1949847 Review. German.
Primary Thromboprophylaxis in Patients with Malignancies: Daily Practice Recommendations by the Hemostasis Working Party of the German Society of Hematology and Medical Oncology (DGHO), the Society of Thrombosis and Hemostasis Research (GTH), and the Austrian Society of Hematology and Oncology (ÖGHO).
Kirschner M, do Ó Hartmann N, Parmentier S, Hart C, Henze L, Bisping G, Griesshammer M, Langer F, Pabinger-Fasching I, Matzdorff A, Riess H, Koschmieder S. Kirschner M, et al. Among authors: pabinger fasching i. Cancers (Basel). 2021 Jun 10;13(12):2905. doi: 10.3390/cancers13122905. Cancers (Basel). 2021. PMID: 34200741 Free PMC article. Review.
58 results